Advertisement
Singapore markets closed
  • Straits Times Index

    3,332.80
    -10.55 (-0.32%)
     
  • Nikkei

    39,583.08
    +241.54 (+0.61%)
     
  • Hang Seng

    17,718.61
    +2.14 (+0.01%)
     
  • FTSE 100

    8,164.12
    -15.56 (-0.19%)
     
  • Bitcoin USD

    60,710.35
    +76.05 (+0.13%)
     
  • CMC Crypto 200

    1,262.69
    -21.14 (-1.65%)
     
  • S&P 500

    5,460.48
    -22.39 (-0.41%)
     
  • Dow

    39,118.86
    -45.20 (-0.12%)
     
  • Nasdaq

    17,732.60
    -126.08 (-0.71%)
     
  • Gold

    2,336.90
    +0.30 (+0.01%)
     
  • Crude Oil

    81.46
    -0.28 (-0.34%)
     
  • 10-Yr Bond

    4.3430
    +0.0550 (+1.28%)
     
  • FTSE Bursa Malaysia

    1,590.09
    +5.15 (+0.32%)
     
  • Jakarta Composite Index

    7,063.58
    +95.63 (+1.37%)
     
  • PSE Index

    6,411.91
    +21.33 (+0.33%)
     

ASX Growth Companies With Strong Insider Ownership June 2024

Amidst a mixed performance in the Australian market, with the ASX200 experiencing a downturn while industrials show resilience, investors may find reassurance in growth companies with high insider ownership. Such stocks often suggest a commitment from those who know the company best, potentially offering stability and confidence in turbulent times.

Top 10 Growth Companies With High Insider Ownership In Australia

Name

Insider Ownership

Earnings Growth

Hartshead Resources (ASX:HHR)

13.9%

86.3%

Cettire (ASX:CTT)

28.7%

30.1%

Acrux (ASX:ACR)

14.6%

115.3%

Plenti Group (ASX:PLT)

12.8%

106.4%

Hillgrove Resources (ASX:HGO)

10.4%

45.4%

Change Financial (ASX:CCA)

26.6%

76.4%

Botanix Pharmaceuticals (ASX:BOT)

11.4%

120.9%

Liontown Resources (ASX:LTR)

16.4%

62.8%

CardieX (ASX:CDX)

12.2%

115.3%

SiteMinder (ASX:SDR)

11.3%

72.7%

Click here to see the full list of 90 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.

ADVERTISEMENT

Underneath we present a selection of stocks filtered out by our screen.

Botanix Pharmaceuticals

Simply Wall St Growth Rating: ★★★★★★

Overview: Botanix Pharmaceuticals Limited, based in Australia, focuses on the research and development of dermatology and antimicrobial products with a market capitalization of A$567.05 million.

Operations: The company generates revenue primarily through its research and development activities in the dermatology and antimicrobial sectors, totaling A$0.44 million.

Insider Ownership: 11.4%

Revenue Growth Forecast: 120.4% p.a.

Botanix Pharmaceuticals, an Australian growth company with high insider ownership, is poised for significant expansion. Its revenue is expected to surge by 120.4% annually, outpacing the national market's 5.5% growth rate. Although currently unprofitable with less than A$1 million in annual revenue and limited cash runway, Botanix is forecasted to achieve profitability within three years and a very high Return on Equity of 43.9%. Recent discussions have focused on upcoming commercial strategies as it approaches the potential approval of SofdraÔ.

ASX:BOT Ownership Breakdown as at Jun 2024
ASX:BOT Ownership Breakdown as at Jun 2024

Chrysos

Simply Wall St Growth Rating: ★★★★★☆

Overview: Chrysos Corporation Limited focuses on the development and supply of mining technology, with a market capitalization of approximately A$655.35 million.

Operations: The company generates revenue primarily from its mining technology services, totaling A$34.24 million.

Insider Ownership: 21.4%

Revenue Growth Forecast: 35.3% p.a.

Chrysos Corporation Limited, an Australian growth company with high insider ownership, is navigating a complex landscape. While the company is set to become profitable within three years with a forecasted revenue growth of 35.3% per year, it faces challenges like low expected Return on Equity at 7.8% and recent significant insider selling. Despite these hurdles, analysts anticipate a potential stock price increase of 33.5%. Upcoming Q3 results on April 23, 2024, may provide further insights into its trajectory.

ASX:C79 Ownership Breakdown as at Jun 2024
ASX:C79 Ownership Breakdown as at Jun 2024

SiteMinder

Simply Wall St Growth Rating: ★★★★★☆

Overview: SiteMinder Limited is an Australian company that develops, markets, and sells online guest acquisition platforms and commerce solutions for accommodation providers globally, with a market capitalization of approximately A$1.42 billion.

Operations: The company generates its revenue primarily through software and programming services, totaling approximately A$171.70 million.

Insider Ownership: 11.3%

Revenue Growth Forecast: 19.7% p.a.

SiteMinder, an Australian growth company with substantial insider ownership, has demonstrated consistent revenue and earnings growth, increasing by 14.9% annually over the past five years. Expected to achieve profitability within three years, its revenue is projected to grow at 19.7% annually, outpacing the Australian market's average of 5.5%. Recently, SiteMinder formed a strategic partnership with Cloudbeds to enhance platform connectivity and expand distribution capabilities for hoteliers globally, promising improved operational efficiency and revenue opportunities.

ASX:SDR Earnings and Revenue Growth as at Jun 2024
ASX:SDR Earnings and Revenue Growth as at Jun 2024

Seize The Opportunity

Looking For Alternative Opportunities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include ASX:BOTASX:C79 and ASX:SDR.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com